Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 112   

Articles published

SHP 4,923.00 +36.00 (0.74%)
price chart
Will The US Block Shire PLC's Buyout And Prevent A Takeover Of AstraZeneca ...
When it was announced, investors celebrated the announcement that US pharmaceutical giant, AbbVie was making a �32bn takeover offer for Shire (LSE: SHP) (NASDAQ: SHPG.US). However, as the dust settles there is a growing amount of speculation that ...
GlaxoSmithKline plc Beats AstraZeneca plc And Shire PLC In The ...
Pfizer's bid for AstraZeneca (LSE: AZN) (NYSE: AZN.US) pushed the share price skywards, and in the other direction GlaxoSmithKline (LSE: GSK) (NYSE: GSK.
Shire PLC Receives Average Recommendation of �Buy� from Analysts (LON:SHP)
Shire PLC logo Shire PLC (LON:SHP) has been given an average recommendation of �Buy� by the twenty-six brokerages that are covering the stock, Analyst RN reports.
Shire PLC Receives Average Rating of "Buy" from Analysts (LON:SHP)  Watch List News (press release)
Related articles »  
Shire plc: Term Loan Credit Agreement
On August 18, 2014, AbbVie Holdings Private Limited (as borrower) and AbbVie Inc. ("AbbVie") and AbbVie Private Limited (as guarantors) entered into a Term Loan Credit Agreement (the "Term Loan Credit Agreement") with the financial institutions party ...
Shire (SHPG) Is Today's Pre-Market Laggard Stock
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products.
Related articles »  
Market Update: Morgan Stanley (NYSE:MS) � Form 8.5 (EPT/RI) � Shire Plc
Market Update: Morgan Stanley (NYSE:MS) - Form 8.5 (EPT/RI) - Shire Plc. By Alan Finwick, on August 11th, 2014, 9:00 am in Financial.
Related articles »  
Shire PLC Sees Significant Growth in Short Interest (SHPG)
Shire PLC logo Shire PLC (NASDAQ:SHPG) was the recipient of a significant growth in short interest during the month of July.
Form 8.3 - Shire Plc
Form 8.3 - Shire Plc. August 29, 2014 07:50 AM Eastern Daylight Time. DENVER--(BUSINESS WIRE)--. FORM 8.3. PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY.
Related articles »  
Shire PLC Sees Significant Increase in Short Interest (SHPG)
Shire PLC logo Shares of Shire PLC (NASDAQ:SHPG) were the recipient of a significant increase in short interest during the month of July.
Related articles »  
AbbVie-Shire Deal Still Offers Big Tax Savings Even Without an Inversion
AbbVie Inc. would still reap big tax savings from its $54 billion acquisition of Shire SHPG -0.24% PLC even if the company is unable to take advantage of all the benefits of a new U.K.
AbbVie's Acquisition Of Shire: Skepticism Creates Buying Opportunity  Seeking Alpha (registration)
AbbVie Can Still Benefit From Tax Savings  Bidness Etc
Related articles »